Ipatasertib is an oral, highly specific, investigational medicine designed to target and bind to all three isoforms of AKT. Reference standards of Ipatasertib API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
No Data Found
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
